Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. patients with severe disease covid-19. 2. positive to proof of infection by some other virus such as influenza h1n1, sars, etc. 3. recurrent urinary tract infections. 4. alanine aminotransferase (alt) or aspartate aminotransferase (ast)\> 5 times above its normal limits. 5. pregnant or lactating patients 6. patients receiving antihypertensive medication verapamil, the immunosuppressant cyclosporin a and / or the antipsychotic trifluoperazine. 7. patients with a known allergy or hypersensitivity to dewormers. 8. patients who are using an antioxidant supplement. 9. patients with a history of filariasis, strongyloidiasis, scabies, river blindness, or any parasitic disease in the last twelve months.

1. patients with severe disease covid-19. 2. positive to proof of infection by some other virus such as influenza h1n1, sars, etc. 3. recurrent urinary tract infections. 4. alanine aminotransferase (alt) or aspartate aminotransferase (ast)\> 5 times above its normal limits. 5. pregnant or lactating patients 6. patients receiving antihypertensive medication verapamil, the immunosuppressant cyclosporin a and / or the antipsychotic trifluoperazine. 7. patients with a known allergy or hypersensitivity to dewormers. 8. patients who are using an antioxidant supplement. 9. patients with a history of filariasis, strongyloidiasis, scabies, river blindness, or any parasitic disease in the last twelve months.

Nov. 16, 2021, 6:30 p.m. usa

patients with severe disease covid-19. positive to proof of infection by some other virus such as influenza h1n1, sars, etc. recurrent urinary tract infections. alanine aminotransferase (alt) or aspartate aminotransferase (ast)> 5 times above its normal limits. pregnant or lactating patients patients receiving antihypertensive medication verapamil, the immunosuppressant cyclosporin a and / or the antipsychotic trifluoperazine. patients with a known allergy or hypersensitivity to dewormers. patients who are using an antioxidant supplement. patients with a history of filariasis, strongyloidiasis, scabies, river blindness, or any parasitic disease in the last twelve months.

patients with severe disease covid-19. positive to proof of infection by some other virus such as influenza h1n1, sars, etc. recurrent urinary tract infections. alanine aminotransferase (alt) or aspartate aminotransferase (ast)> 5 times above its normal limits. pregnant or lactating patients patients receiving antihypertensive medication verapamil, the immunosuppressant cyclosporin a and / or the antipsychotic trifluoperazine. patients with a known allergy or hypersensitivity to dewormers. patients who are using an antioxidant supplement. patients with a history of filariasis, strongyloidiasis, scabies, river blindness, or any parasitic disease in the last twelve months.

Oct. 26, 2020, 11:31 p.m. usa

1. patients with severe disease covid-19. 2. positive to proof of infection by some other virus such as influenza h1n1, sars, etc. 3. recurrent urinary tract infections. 4. alanine aminotransferase (alt) or aspartate aminotransferase (ast)> 5 times above its normal limits. 5. pregnant or lactating patients 6. patients receiving antihypertensive medication verapamil, the immunosuppressant cyclosporin a and / or the antipsychotic trifluoperazine. 7. patients with a known allergy or hypersensitivity to dewormers. 8. patients who are using an antioxidant supplement. 9. patients with a history of filariasis, strongyloidiasis, scabies, river blindness, or any parasitic disease in the last twelve months.

1. patients with severe disease covid-19. 2. positive to proof of infection by some other virus such as influenza h1n1, sars, etc. 3. recurrent urinary tract infections. 4. alanine aminotransferase (alt) or aspartate aminotransferase (ast)> 5 times above its normal limits. 5. pregnant or lactating patients 6. patients receiving antihypertensive medication verapamil, the immunosuppressant cyclosporin a and / or the antipsychotic trifluoperazine. 7. patients with a known allergy or hypersensitivity to dewormers. 8. patients who are using an antioxidant supplement. 9. patients with a history of filariasis, strongyloidiasis, scabies, river blindness, or any parasitic disease in the last twelve months.